Lv11
60 积分 2025-08-01 加入
Mineralocorticoid receptor antagonists and aldosterone synthase inhibitors: agent comparison with implications for clinical practice and trial design
2分钟前
待确认
An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs
2个月前
已完结
Comparison table: Some drugs for weight management
3个月前
已关闭
Comparative Efficacy of Endoscopic Sleeve Gastroplasty (Esg) Versus Liraglutide in Weight Loss and Remission Of Obesity-Related Comorbidities: Twelve Months Follow-Up Results
3个月前
已完结
Combined Use of Empagliflozin and Liraglutide Protects Against Tacrolimus-Induced Pancreatic and Kidney Injury through Suppression of Oxidative Stress
3个月前
已完结
Agonistas del receptor GLP-1 y co-agonistas GIP/GLP-1 en el tratamiento de la obesidad en adolescentes y ancianos
3个月前
已完结
Agonistas del receptor GLP-1 y co-agonistas GIP/GLP-1 en el tratamiento de la obesidad en adolescentes y ancianos
3个月前
已完结
The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses
3个月前
已完结
Efficacy and Safety of GLP‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
3个月前
已完结
皖公网安备34019202002308
